engpass.radar
engpass.radarSwiss drug shortages
Last sync: 20/05/2026

709

medicines in Switzerland are currently reported as unavailable.

Aggregated from drugshortage.ch, the BWL mandatory stockpile and the USB Basel list. Synced daily, publicly accessible. Methodology & sources →

New · CW 21

+7

Resolved · CW 21

−3

≥ 6 months active

21931 %

Archive

8’672since 2016
Export current view as CSV

More views

HistoricalResolved shortages since 20168’672Off marketDiscontinued · Withdrawn · Off market83’886

How it works

How it works

  1. 01

    All sources, one dashboard

    The latest shortage notifications from every official Swiss source — reconciled daily, so you don't have to check three portals yourself.

  2. 02

    Instantly enriched

    Active substance, ATC code and manufacturer are automatically attached. No manual lookups, no copy-paste between systems.

  3. 03

    Find instead of search

    Full-text search, filters by manufacturer or ATC group, a detail page per product. Publicly accessible, no registration required.

What you'll find here

What you'll find here

01

Data

  • All sources unified

    drugshortage.ch + BWL + ODDB

  • Updated daily

    Automatic, with visible timestamp

  • Severity Score

    Duration · alternatives · BWL status

  • Trend timeline

    Weekly view of how shortages evolve

02

Search & filter

  • Full-text search

    Active substance, product, manufacturer

  • ATC filter

    All affected ATC groups

  • Status & manufacturer filter

    Combinable, no reload

  • Alternative suggestions

    Products with the same active substance

03

Interfaces

  • CSV export

    Up-to-the-day raw data

  • REST API

    JSON, filterable, no registration

  • Webhooks

    Push on new shortages (API plan)

  • Publicly accessible

    No login, no paywall

Frequently asked questions

Frequently asked questions

01Who is behind engpass.radar?

engpass.radar is an independent project from clinical practice in Switzerland. No pharma sponsor, no advertising, no affiliate links. Built out of real-world clinical need and run in private time.

02Where does the data come from?

Shortage notifications come primarily from drugshortage.ch. Data from the Federal Office for National Economic Supply (BWL) and the shortage list of the hospital pharmacy at the University Hospital Basel are added on top. Active substance, ATC code, Swissmedic number and GTIN come from the public ODDB reference database.

03How current is the data?

The data is reconciled automatically every day. The header shows when the last import ran. If a sync ever fails, the timestamp makes it visible — no stale state is presented as current.

04Is the list complete?

engpass.radar shows what is reported in the aggregated sources — nothing more, nothing less. Unreported shortages will not appear here. For information that is regulatory in nature, the primary source is always authoritative.

05Does it cost anything?

The dashboard, search, detail pages, CSV export and the basic API are publicly accessible. Higher API quotas, white-label integrations and SLA-backed Institutional plans are paid — these are aimed at software vendors and hospital pharmacy chains. Details at /api.

06Can I reuse the data or integrate it into my own system?

Yes. A CSV export is available, and a public REST API lives at engpassradar.ch/api-docs. The free tier works without an account. For productive integrations, Professional and Institutional plans offer higher quotas and an SLA.

07May I use engpass.radar in hospital or pharmacy operations?

Yes — as an information and monitoring tool. For pharmaceutical or clinical decisions, the primary source (drugshortage.ch, Swissmedic, BWL) is authoritative. The monthly report and the Engpass-Signal newsletter are citable and may be circulated internally.

08Liability and warranty

engpass.radar is an information tool, not an official register. The display, score and alternative hints are aggregated automatically; errors in the primary source are passed through unchanged. For clinical, pharmaceutical or regulatory decisions, only the official sources apply.